These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6433507)

  • 21. C3bi/CR3 is a main ligand-receptor interaction in attachment and phagocytosis of C3-coated particles by mouse peritoneal macrophages.
    Kimura M; Griffin FM
    Scand J Immunol; 1992 Aug; 36(2):183-91. PubMed ID: 1502493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
    Gerdes J; Klatt U; Stein H
    Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of divalent cations on the stability of human rotavirus.
    Shirley JA; Beards GM; Thouless ME; Flewett TH
    Arch Virol; 1981; 67(1):1-9. PubMed ID: 6263223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Necessity of the divalent cation in the reaction between EAC1-8hu and C9gp.
    Kitamura H; Matsumoto M; Inai S
    Int Arch Allergy Appl Immunol; 1976; 51(2):265-71. PubMed ID: 819379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of divalent cations in binding polymorphonuclear leucocytes to glomeruli with immune complexes.
    Yamamoto T; Kihara I; Morita T; Oite T; Suzuki Y
    Clin Exp Immunol; 1980 Mar; 39(3):583-7. PubMed ID: 6769622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the alternative (properdin) pathway by divalent cations.
    Lew FT; Yukiyama Y; Waks HS; Osler AG
    J Immunol; 1975 Sep; 115(3):884-8. PubMed ID: 807649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trypan blue inhibition of complement receptor function on various cells.
    Harper BL; Fine DP; Guckian JC; Cavallo T
    Immunology; 1981 Jan; 42(1):61-6. PubMed ID: 7461725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human complement receptor type 3.
    Arnaout MA; Pierce MW; Dana N; Clayton LK
    Methods Enzymol; 1987; 150():602-15. PubMed ID: 3323792
    [No Abstract]   [Full Text] [Related]  

  • 29. Complement receptors on guinea pig epidermal Langerhans cells.
    Berman B; Gigli I
    J Immunol; 1980 Feb; 124(2):685-90. PubMed ID: 7356709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of divalent cations, quinolones and bacteria.
    Marshall AJ; Piddock LJ
    J Antimicrob Chemother; 1994 Oct; 34(4):465-83. PubMed ID: 7868402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
    Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
    Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic effects of normal sera on lymphoid cells. II. Requirements for inhibition of nonspecific serum cytotoxicity by agarose.
    Budzko DB; Kierszenbaum F
    Transplantation; 1977 Apr; 23(4):337-42. PubMed ID: 405760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement receptor expression by neoplastic and normal human cells.
    Gaither TA; Magrath IT; Berger M; Hammer CH; Novikovs L; Santaella M; Frank MM
    J Immunol; 1983 Aug; 131(2):899-905. PubMed ID: 6306108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of divalent cations and functionally related substances on the yeast to mycelium transition in Sporothrix schenckii.
    Alsina A; Rodríguez-Del Valle N
    Sabouraudia; 1984; 22(1):1-5. PubMed ID: 6422568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum.
    Ramos OF; Sármay G; Klein E; Yefenof E; Gergely J
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5470-4. PubMed ID: 3895232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro complement activation by rabbit lymphocytes and thymocytes in autologous serum.
    Wilson AB; Lachmann PJ; Coombs RR
    Immunology; 1979 May; 37(1):25-34. PubMed ID: 112041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway.
    Hidvégi T; Füst G; Rajnavölgyi E; Kulics J; Gergely J
    Immunology; 1985 Dec; 56(4):735-41. PubMed ID: 3935572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assays for membrane complement receptors.
    O'Rear LD; Ross GD
    Curr Protoc Immunol; 2001 May; Chapter 13():13.4.1-13.4.18. PubMed ID: 18432717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
    Fearon DT
    J Exp Med; 1980 Jul; 152(1):20-30. PubMed ID: 6967510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of E-and EAC-rosette formation by gentamicin, ampicillin and tetracycline.
    Nualart P; Sen L; Estevez ME; Diez RA
    Biomed Pharmacother; 1985; 39(4):187-91. PubMed ID: 3933589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.